The U.S. Food and Drug Administration (FDA) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals Inc.

This is a preview. Log in through your library . Abstract Background Studies have suggested that clinicians do not feel comfortable with the interpretation of symptom severity, functional status, and ...